Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze ALNY stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ALNY investment potential.

What is ALNY stock price today?

Get real-time ALNY stock price, historical data, and price charts on Financhill. Track ALNY performance with our advanced analysis tools.

Is ALNY a good investment?

Evaluate ALNY investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ALNY stock?

To buy ALNY stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ALNY?

View detailed market capitalization data and company valuation metrics for ALNY on our comprehensive analysis page.

What is the P/E ratio of ALNY?

Use our fundamental analysis tools to view ALNY P/E ratio and compare valuation metrics with industry peers.

What are ALNY earnings?

View ALNY earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Alnylam Pharmaceuticals, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

ALNY
Alnylam Pharmaceuticals, Inc.

Last Price:

$318.65

Seasonality Move:

9.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Alnylam Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Alnylam Pharmaceuticals, Inc. has on average historically risen by 31.3% based on the past 21 years of stock performance.
Alnylam Pharmaceuticals, Inc. has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%
Is Alnylam Pharmaceuticals, Inc. Stock Undervalued?

The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $318.85. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Alnylam Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Alnylam Pharmaceuticals, Inc. has on average historically risen by 31.3% based on the past 21 years of stock performance.

Alnylam Pharmaceuticals, Inc. Stock Rating

Sell

Alnylam Pharmaceuticals, Inc. (ALNY) is a Sell

Is Alnylam Pharmaceuticals, Inc. overpriced?

Alnylam Pharmaceuticals, Inc. has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%

Alnylam Pharmaceuticals, Inc. Stock Price History

Is ALNY stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

alnylam.com

52-Week Data

52-Week High:

495.55

52-Week Low:

205.87

Prediction Charts

Market Cap:

41B

Price in USD:

318.85

Volume:

872.4K

Beta:

1.18

Technical Analysis

SMA50:

328.67

SMA100:

372.72

SMA200:

393.24

52-Wk Change:

19.5%

Stock Predictions

Is Alnylam Pharmaceuticals, Inc. stock public?

Yes, Alnylam Pharmaceuticals, Inc. is a publicly traded company.
What is the Alnylam Pharmaceuticals, Inc. stock quote today?

The Alnylam Pharmaceuticals, Inc. stock price is 318.85 USD today.
How to buy Alnylam Pharmaceuticals, Inc. stock online?

You can buy Alnylam Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Mar-16	311.22	318.91	319.55	311.22
Mar-17	319.63	320.42	326.96	317.53
Mar-18	317.50	314.80	319.27	312.58
Mar-19	316.42	311.10	317.61	309.73
Mar-20	311.05	312.17	322.43	311.05
Mar-23	320.77	306.66	323.23	304.38
Mar-24	303.42	308.05	308.91	299.62
Mar-25	313.34	328.70	329.48	311.71
Mar-26	328.90	328.16	332.81	327.69
Mar-27	327.10	317.36	329.69	316.85
Mar-30	319.32	316.09	321.76	314.21
Mar-31	319.06	330.87	332.48	318.37
Apr-1	332.69	328.73	335.48	327.59
Apr-2	323.03	318.85	325.49	315.90

Alnylam Pharmaceuticals, Inc. Earnings

Alnylam Pharmaceuticals, Inc. Earnings Report: Per Share Alnylam Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Alnylam Pharmaceuticals, Inc. Forecast Revenue Growth

Alnylam Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.86 per share, an increase next quarter of $0.84 per share, an increase this year of $4.46 per share, and an increase next year of $4.95 per share.

* Alnylam Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.